EPCAM and neoplasm: The EpCAM BiTE secreted from infected malignants effectively mediated the binding of EpCAM-positive tumor cells and CD3ε on T cells, which led to activation of naive T-cell and the release of cytokines, such as IFN-γ and IL-2.